Fact-checked by Grok 2 weeks ago

Merative

Merative is an healthcare that provides , , and software solutions to support clinical decision-making, , generation, and health and delivery. Headquartered in , it serves providers, payers, pharmaceutical companies, and government agencies, including nine of the top ten U.S. hospitals, seven of the top ten U.S. payers by enrollment, and all of the top twenty pharmaceutical companies. The company focuses on transforming healthcare organizations into insights-driven entities by unlocking the value of through actionable intelligence and trusted . Originally part of IBM's Watson Health division, Merative traces its roots to nearly five decades of healthcare innovation, including legacy assets like Truven Health Analytics and Micromedex. In June 2022, private equity firm acquired select IBM Health assets—encompassing data and analytics tools—and relaunched them as the independent company Merative LP. This spin-off allowed Merative to operate autonomously, emphasizing a people-centered approach to while building on IBM's established expertise in areas like AI-driven clinical support and management. Under CEO , who brings extensive experience in healthcare IT, the company has prioritized innovation in real-world data platforms such as MarketScan and specialized solutions like Cúram for government . Merative's core offerings include Micromedex for evidence-based clinical decision support, Merge for advanced workflows, Truven analytics for personalized care and cost optimization, and Zelta for data management. It also supports over 35 state, local, and federal government agencies in streamlining service delivery and 40% of 100 employers in employee health programs. By integrating , technology, and comprehensive datasets like linked electronic health records (EHRs) and claims data, Merative aims to address key challenges in healthcare efficiency, equity, and outcomes.

History

Origins and Development under IBM

The foundational assets of what would become Merative originated with Micromedex, established in 1973 as a specialized resource to provide critical information on poisons and treatments for healthcare professionals. Initially developed under the auspices of early medical informatics efforts, Micromedex focused on evidence-based data for emergency response and poison control, drawing from collaborations with toxicologists and regional poison centers. By the , it had evolved into a comprehensive clinical decision support tool, incorporating monographs, management guidelines, and laboratory information to aid broader diagnostic and therapeutic decisions across hospital and pharmacy settings. IBM's entry into healthcare technology accelerated the development of these precursors through strategic acquisitions and the launch of Watson Health in April 2015, a dedicated unit aimed at leveraging for data aggregation, analysis, and insights in life sciences, providers, and payers. That same year, IBM acquired Merge Healthcare for $1 billion, integrating its management into Watson Health to enable advanced image analytics and workflow tools for and diagnostics. Earlier, in 2011, IBM had acquired Cúram Software, expanding its social to support government health initiatives, including eligibility determination, case management, and integration with public welfare systems for coordinated care delivery. In 2016, IBM further bolstered its capabilities by acquiring Truven Health Analytics for $2.6 billion, incorporating the —a vast repository of de-identified healthcare claims data covering over 300 million patient lives—to facilitate outcomes , cost analysis, and studies. This acquisition enhanced Health's data aggregation efforts, allowing for AI-driven correlations between clinical, financial, and administrative datasets to inform value-based care models. These developments under positioned the assets for a transition to independence as Merative in 2022.

Spin-off and Independence

In January 2022, announced an agreement to sell its healthcare data and analytics assets, previously part of Watson Health, to for an undisclosed amount, paving the way for the creation of Merative LP as a standalone entity. The transaction, completed in June 2022, transferred key assets including extensive datasets and products focused on clinical, , and solutions. Merative officially launched on June 30, 2022, as a data and analytics company headquartered in , dedicated to providing health solutions for providers, payers, and life sciences organizations. Under initial CEO Gerry McCarthy, the company emphasized its six core product lines: Cúram for social program management, Health Insights for analytics, MarketScan for commercial healthcare claims data, Merge for , Micromedex for clinical decision support, and Zelta for solutions. This structure allowed Merative to operate independently while building on legacy technologies such as for enhanced . Post-spin-off, Merative achieved key milestones, including the establishment of global capability and innovation centers in , , and , , in August 2023 to bolster and data expertise. In December 2024, the company secured a $25 million strategic from Morgan Health, a unit, to advance tools for analyzing employer-sponsored health data and improving benefit decision-making. These developments underscored Merative's focus on scaling its independent operations amid evolving healthcare demands.

Products and Services

Clinical Decision Support Solutions

Merative's flagship clinical decision support solution, Micromedex, delivers evidence-based information on drugs, diseases, and to aid healthcare professionals in making informed patient care decisions. Curated by clinical experts from primary and peer-reviewed sources, it supports point-of-care access through and platforms, enabling rapid retrieval of reliable insights. Trusted in over 80 countries, Micromedex has been a cornerstone for control centers, hospitals, and pharmacies worldwide. Key features include comprehensive drug interaction checkers that evaluate , drug-food, drug-lab, and drug-disease interactions for individual medications or medication lists, along with IV compatibility tools and drug identification by physical characteristics. Dosing calculators provide tailored recommendations based on factors such as , , and renal , while lab interpretation resources detail potential interferences and clinical implications. The toxicology database, Poisindex, covers over 470,000 commercial products, chemicals, , toxic plants, and animals. Content is updated regularly to reflect the latest evidence, ensuring clinicians have access to current guidelines and monographs for more than 2,500 . Micromedex integrates seamlessly with electronic health records (EHRs) and electronic medical records (EMRs), allowing embedded access at the point of care to streamline workflows and support real-time decision-making. Recent advancements incorporate AI-powered search capabilities, launched in 2025, which accelerate answers to clinical queries while citing trusted sources to maintain accuracy and alignment with standards. This evolution enhances alert systems for potential adverse events by providing faster, context-aware insights. Originating in 1973 with a focus on content delivered via microfiche, Micromedex has evolved over 50 years into a that has significantly contributed to reducing errors. For instance, with EHRs has enabled organizations to review up to 96% of prescriptions, minimizing risks through proactive checks. By providing comprehensive, evidence-based databases, it has supported safer prescribing practices and improved clinical outcomes across diverse healthcare settings.

Data Analytics and Research Platforms

Merative's data analytics and research platforms enable the analysis of large-scale, de-identified healthcare datasets to inform outcomes research, policy decisions, and operational improvements in healthcare systems. These platforms leverage longitudinal claims and real-world evidence to support population-level insights, distinct from patient-specific clinical tools. The MarketScan Research Database is a proprietary collection of individual-level, de-identified healthcare claims data sourced from U.S. employers, health plans, hospitals, Medicare, and Medicaid programs. It encompasses over 293 million unique patients with longitudinal records dating back to the early 1990s, providing comprehensive coverage of inpatient, outpatient, pharmacy, and enrollment details. In Fall 2025, the MarketScan Medicare Database expanded to offer three times more annual lives and an 80% year-over-year increase in lab values. This database facilitates outcomes research by tracking treatment patterns and disease progression, cost analysis through actual utilization and expenditure data, and drug effectiveness studies via real-world evidence on therapy impacts. It has supported over 4,500 peer-reviewed publications in health economics and related fields. The Health Insights platform, also known as Truven Health Insights, serves as a flexible analytics solution for integrating and exploring healthcare data to deliver actionable benchmarks and performance evaluations. It aggregates claims, clinical, and financial data to enable benchmarking of provider performance against industry, regional, and peer standards, incorporating quality metrics such as care utilization rates and financial analytics like cost per episode for hospitals and payers. Users can assess population health trends, optimize resource allocation, and identify cost-saving interventions through interactive dashboards and self-service tools. Zelta is a cloud-based, unified platform for and acquisition, designed to streamline clinical trials across all phases with modular, customizable tools. It includes (EDC) for secure , clinical trial management system (CTMS) features for site selection and oversight, and patient recruitment modules that enhance engagement among participants, caregivers, and providers. The platform supports workflow automation for study setup, adherence, and real-time data monitoring, having hosted over 4,500 trials, including more than 500 Phase III studies. Key capabilities across these platforms include predictive modeling powered by longitudinal data spanning over 15 years, such as the Risk of Hospitalization model, which forecasts admission probabilities to inform proactive care management and reduce readmissions. Additional modeling supports resource utilization predictions by analyzing historical patterns in costs, service use, and patient trajectories, aiding payers and providers in allocating resources efficiently.

Imaging and Workflow Tools

Merative's Merge Imaging Suite provides a cloud-native platform for managing data, encompassing tools like the Merge PACS () designed to store, retrieve, and distribute images such as X-rays, scans, and MRIs across healthcare enterprises. This system consolidates patient imaging data from multiple sources into a unified , enabling efficient access for radiologists and clinicians while supporting remote reading capabilities to scale care delivery. By leveraging a rule-based engine, Merge PACS automates workload balancing and simplifies diagnostic reading workflows, reducing manual tasks and improving operational efficiency in radiology departments. The suite includes advanced tools, such as the Merge Workflow Orchestrator, which unifies worklists and consolidates information into a single, patient-centered view for clinicians. These tools facilitate reporting by automating case assignment, enhancing collaboration among care teams, and providing end-to-end visibility into processes, thereby streamlining prioritization and reducing turnaround times for interpretations. is achieved through support for standards like for image exchange, HL7 for messaging, and IHE profiles, allowing seamless integration with electronic health records (EHRs), radiology information systems (RIS), and imaging devices. For enterprise imaging, Merative offers vendor-neutral archiving (VNA) via Merge VNA, a scalable solution that securely stores and shares both and non- from diverse vendors, eliminating silos and enabling long-term with options for , on-premise, or deployments. This VNA incorporates prefetching rules, customizable dashboards, and EHR integrations to boost workflow efficiency and provide real-time analytics for imaging operations. Additionally, -specific modules within the suite, such as Merge Cardio and Merge Hemo, manage comprehensive image and information systems for the service line, supporting (echo) reporting and catheterization (cath) workflows to centralize and simplify clinician . Since its 2022 spin-off, Merative has enhanced these tools through partnerships, notably with Aidoc, to integrate models that automate , , and in workflows, such as flagging critical findings for faster . These capabilities build on broader advancements in for imaging, including generative for report drafting and intelligent worklist prioritization, to further optimize diagnostic accuracy and physician productivity.

Technological Advancements

AI and Analytics Innovations

Merative has integrated into its Micromedex platform to enhance clinical decision support, particularly for querying drug-related information such as interactions and dosing. Launched in September 2025, the AI-powered search functionality leverages algorithms trained on curated repositories to deliver rapid, evidence-based responses to clinician queries, including those on drug interactions and patient-specific scenarios like pediatric . This approach supports by providing accurate access to information on adverse effects and compatibility, validated through internal testing, external clinician review, and real-world adoption by health systems such as Singing River Health System. Conversational AI features further advance Merative's clinical tools by enabling natural language interactions for evidence-based recommendations. Utilizing (NLP) and generative AI, these capabilities allow clinicians to pose intuitive questions—such as medication safety during pregnancy—drawing from trusted content to streamline workflows and improve efficiency. Integrated into platforms like Micromedex, this technology facilitates precise, cited responses, reducing the time needed for while maintaining alignment with clinical evidence standards. Early implementations, including the 2025 AI search rollout, demonstrate its potential to optimize medication management and organizational processes. In analytics, Merative's MarketScan Research Databases incorporate to extract insights from unstructured (EHR) data, enhancing research capabilities. By linking claims data with -processed EHRs from partners like , the platform enables deeper analysis of patient journeys, healthcare utilization, and costs, such as in studies. This enhancement improves cohort identification for generation, providing unparalleled depth into clinical outcomes from de-identified, large-scale datasets covering millions of patients. Merative's innovation emphasizes explainable to promote in diagnostic and clinical suggestions. Through features like detailed rationales accompanying outputs in Micromedex, the company ensures clinicians can understand the basis of recommendations, fostering and safe into workflows. This focus aligns with broader principles of in healthcare, though specific strategies for addressing bias via diverse datasets remain part of ongoing industry-wide efforts rather than uniquely detailed in Merative's public disclosures.

Partnerships with Technology Providers

Merative has forged strategic alliances with prominent technology providers to integrate cloud infrastructure, capabilities, and tools into its healthcare platforms, enhancing scalability and for clinical and research applications. A key partnership with centers on the deployment of the Merge Imaging Suite on the Marketplace, announced at RSNA 2023. This collaboration enables cloud-native deployment of enterprise imaging solutions, supporting hybrid-cloud environments and facilitating efficient -driven workflows for and . By 2024, Merge solutions were fully transactable via , allowing healthcare organizations to leverage Microsoft's ecosystem for seamless and reduced infrastructure commitments. In the realm of data analytics, Merative partnered with Kyvos Insights in 2023 to modernize healthcare analytics architectures. This OEM alliance integrates Kyvos' hyperconverged analytics platform with Merative's solutions, enabling faster querying of large datasets on cloud infrastructure to support evidence-based decision-making in real-world evidence generation. For real-world data access, Merative's MarketScan databases are hosted on Snowflake's cloud data platform, providing immediate, secure access to claims and encounter data without lengthy on-premises setups. This integration, emphasized in 2023 updates, minimizes deployment times and costs while ensuring compliance for research teams analyzing population health trends. Merative has also collaborated with specialized AI technology providers to bolster imaging innovations. In 2023, a with Indica Labs incorporated workflows into the Merge Imaging Suite, allowing seamless integration of AI-assisted analysis for slides within enterprise systems. Similarly, in 2024, Merative teamed with Therapixel to embed AI-powered detection tools into Merge platforms, improving diagnostic accuracy through cloud-enabled image processing. In November 2025, Merative partnered with Us2.ai to integrate FDA-cleared algorithms for analysis into the Merge Cardio platform, enhancing automated diagnostic workflows in . Looking ahead, Merative's 2025 initiatives include expanded collaborations with technology providers to advance applications in management, building on prior and analytics integrations to address evolving industry needs.

Healthcare Applications

Diagnostic and Imaging Support

Merative's Merge imaging solutions play a pivotal role in by leveraging to enhance image interpretation and support the detection of various conditions, including s suggestive of tumors and bone fractures. These tools integrate advanced algorithms that analyze radiographic data to identify abnormalities, thereby assisting radiologists in prioritizing critical findings. For instance, an -driven workflow for detection has demonstrated a 23% improvement in efficiency over traditional manual methods, particularly for cases involving multiple nodules, allowing for faster and reduced interpretation times. Complementing imaging capabilities, Merative's Micromedex, integrated into the DynaMedex platform, provides robust support for disease diagnosis through symptom-based search functionalities that generate differential diagnoses and link to evidence-based treatment protocols. This clinical decision support resource covers nearly 3,200 disease and condition topics, enabling healthcare providers to systematically evaluate symptoms against a comprehensive database of clinical scenarios. The AI-powered search within DynaMedex delivers cited, evidence-based results to inform diagnostic reasoning and protocol adherence. Merge's workflows facilitate multi-modal diagnostics by unifying data from diverse sources such as , MRI, and scans, enabling side-by-side comparisons and holistic patient assessments that improve diagnostic accuracy. This integration streamlines the process of correlating findings across modalities to form comprehensive diagnostic pictures, particularly in complex cases requiring layered . In oncology applications, Merative's tools have shown promise in early cancer detection through pattern recognition in imaging datasets. Similarly, the lung nodule detection capabilities have been applied to enhance early-stage lung cancer screening by automating the review of CT datasets for subtle patterns.

Workflow and Records Management

Merative's Cúram software serves as a key platform for integrating social services with healthcare operations, particularly in automating eligibility determination and case management for public health programs. This solution supports end-to-end integrated eligibility and enrollment processes, enabling health and human services organizations to manage complex eligibility rules efficiently and reduce unintended case closings. By incorporating 45+ proven integrations and 19 prebuilt workflows, Cúram facilitates rapid deployment and individualized service delivery for government social programs, transforming how benefits are administered to clients. In terms of (EHR) interoperability, Merative's Health Insights platform enhances through data linkage capabilities, such as combining MarketScan claims data with EHR data to provide a comprehensive view of care across providers. This approach enables seamless exchange of health information, supporting better coordination and reducing silos in patient records. While specific adherence to FHIR standards is a broader practice for such exchanges, Merative's tools leverage to inform operational decisions without requiring manual interventions. Merative offers optimization tools designed to alleviate administrative burdens in hospitals, including features for scheduling, billing, and tracking integrated into provider solutions. These tools prioritize clean, streamlined processes to focus on patient care, with 160+ prebuilt in platforms like Cúram aiding efficient data flow and task . For instance, helps unify disparate systems, improving operational visibility and efficiency in healthcare delivery. Drug interaction management is embedded within Merative's records systems through Micromedex, providing real-time alerts to flag potential issues during prescribing and administration. This evidence-based resource checks for drug interactions, allergies, and contraindications directly in clinical workflows, enhancing patient safety by informing decisions at the point of care. Integration with electronic medical records ensures that Micromedex's comprehensive drug database supports medication management throughout the care continuum.

Research and Telehealth Integration

Merative's Zelta platform plays a key role in supporting telehealth-enabled clinical trials by enabling decentralized trial designs that incorporate virtual site visits and remote patient monitoring for data collection. This unified cloud-based solution facilitates remote patient recruitment, engagement, and real-time data analysis, allowing sponsors to conduct hybrid or fully remote trials efficiently across global sites. By integrating modules such as electronic data capture (EDC), electronic patient-reported outcomes (ePRO), and eConsent, Zelta streamlines participant involvement without requiring physical presence, thereby enhancing accessibility for diverse populations. The platform's MarketScan research databases further advance telehealth integration in clinical research by providing comprehensive real-world evidence (RWE) on virtual care outcomes. Researchers leverage MarketScan's commercial and Medicare claims data to analyze telehealth utilization patterns, efficacy of virtual visits, and associated healthcare costs following the COVID-19 pandemic. For instance, studies have utilized this data to evaluate telehealth's impact on medication adherence for chronic conditions like hypertension and behavioral health service delivery, revealing sustained adoption rates and cost savings in outpatient settings. Merative enhances delivery through secure integrations of its clinical decision support solutions with electronic health records (EHRs), supporting remote consultations via AI-driven features for symptom assessment and . The Micromedex AI-powered search, embedded in workflows, enables providers to quickly retrieve evidence-based guidance during virtual visits, minimizing delays in and improving patient outcomes in remote settings. These capabilities extend to behavioral , where analytics from sources like MarketScan track utilization trends—such as 40% of behavioral health visits occurring via in late 2021—and inform strategies to address access barriers in underserved communities. In recent advancements, Merative's data analytics platforms continue to evolve for global applications, incorporating predictive tools to identify care gaps in underserved areas and optimize for remote healthcare delivery. This focus aligns with broader industry shifts toward hybrid care models, leveraging to refine protocols and expand equitable access worldwide.

Industry Challenges

Competitive Landscape

Merative operates in a highly competitive healthcare sector dominated by tech giants and established players, where it faces significant rivalry in -driven diagnostics and analytics. Microsoft's Nuance, acquired in 2021, leads in diagnostics through tools like Dragon Medical One, which enhances clinical documentation and voice-enabled workflows, directly challenging Merative's clinical decision support offerings. Similarly, 's DeepMind excels in imaging , with applications in detecting eye diseases through retinal imaging analysis and via screening models, positioning it as a formidable competitor in analysis. Intel's Habana Labs provides hardware-accelerated solutions through Gaudi processors, enabling faster training and inference for healthcare analytics, which competes with Merative's data processing capabilities in resource-intensive environments. In terms of , Merative contends with entrenched leaders in electronic health records (EHRs) and . holds the largest share of the acute care hospital EHR market at 42.3% as of 2024, up from 39.1% the previous year, driven by net gains from major health systems adopting its integrated platforms. dominates in and , leveraging vast datasets for clinical trials and analytics, contributing to the global real-world evidence solutions market projected to reach USD 6.92 billion by 2034. Merative differentiates itself through specialized datasets like MarketScan, one of the largest proprietary collections of de-identified U.S. claims spanning , , and populations, enabling unique insights into healthcare utilization and costs. To counter these challenges, Merative emphasizes niche strengths in clinical support and imaging solutions, such as its Merge Imaging Suite for and workflows, which integrates tools to streamline enterprise imaging. The company has pursued strategic growth, including a $25 million investment from Morgan Health in December 2024 to enhance employer-focused analytics, supporting revenue expansion amid sector investments. Broader industry trends, including a surge in mergers and acquisitions among healthcare technology firms in 2024—with deals jumping as profitable entities acquire startups—highlight increasing that favors scale but can limit flexibility. 's independent status as a Francisco Partners-backed entity since its 2022 spin-off from allows for agile partnerships, such as collaborations with benefits providers to deliver actionable health insights, providing an edge over larger conglomerates constrained by internal silos.

Regulatory and Ethical Issues

Merative, as a provider of healthcare data analytics and AI-driven solutions, operates within a stringent regulatory environment focused on protecting patient data and ensuring the safe deployment of technology in clinical settings. The company commits to compliance with key regulations such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, which governs the privacy and security of protected health information (PHI). For instance, in contractual agreements with state health agencies, Merative explicitly adheres to HIPAA standards alongside other privacy laws like the California Consumer Privacy Act (CCPA), implementing measures to safeguard sensitive data during processing and transmission. Internationally, Merative supports compliance with the General Data Protection Regulation (GDPR) through dedicated resources for its Social Program Management products, including documentation to help customers address data protection requirements for EU operations. These efforts underscore Merative's emphasis on organizational, physical, and technological safeguards to prevent unauthorized access to personal health data. Additionally, Merative navigates emerging regulations like the EU AI Act for high-risk AI systems and FDA's 2025 guidance on AI in predictive decision support, ensuring compliance in global deployments. Ethical considerations in Merative's applications, particularly in clinical decision support and practice, center on the responsible handling of sensitive information and mitigating risks like . The company prioritizes "secure and ethical handling" of in its -powered tools, such as Micromedex, ensuring that systems comply with evolving data regulations while promoting person-centric outcomes to avoid disparities in care recommendations. In addressing deployment challenges, Merative highlights the need for rigorous standards to build , including in model development and adherence to principles that support informed clinical decisions without compromising . For integrations, ethical concerns around analyzing are managed through compliance-focused frameworks that navigate regulatory grey areas, aiming to enhance while upholding and . While Merative has not faced publicly reported regulatory violations since its 2022 from , the broader legacy of its predecessor technologies, like Health, has informed industry-wide scrutiny on reliability in healthcare. Past critiques of Watson's recommendations, which occasionally suggested unsafe treatments due to issues, have heightened calls for robust validation in ethics, influencing Merative's current focus on evidence-based, curated data sources to prevent similar pitfalls. This historical context reinforces Merative's proactive stance on regulatory evolution, such as adapting to FDA guidance on in clinical decision support, to ensure accountability and across its portfolio.

References

  1. [1]
    Merative: Healthcare Data, Technology and Analytics
    Health data and technology, centered around you. Merative's aim is to drive real progress by putting people at the center of health and social care.Our company · Careers · Contact us · Leadership
  2. [2]
    About Merative
    We're a data, analytics and technology partner for the health industry. For nearly five decades, we've combined trusted technology and deep industry expertise.
  3. [3]
    Launches Healthcare Data Company Merative - Francisco Partners
    Jun 30, 2022 · It has completed the acquisition of healthcare data and analytics assets that were part of IBM's (NYSE: IBM) Watson Health business.
  4. [4]
    Merative, a new data company, formed from IBM's healthcare ...
    Jul 5, 2022 · Francisco Partners has completed its purchase of Watson Health's data analytics tools and is spinning them off into an Ann Arbor, Michigan-based business.
  5. [5]
    Watson Health reborn as Merative, new owner announces
    Jul 5, 2022 · Francisco Partners celebrated the close of its Watson Health transaction by relaunching IBM's ill-fated analytics business under a new name.
  6. [6]
    Leadership | Merative
    Leadership ; Gerry-McCarthy. Gerry McCarthy. CHIEF EXECUTIVE OFFICER ; Troy Bailey. CHIEF TECHNOLOGY OFFICER ; Brian Bonner. Chief Financial Officer and. CHIEF ...Thought Leadership · Thought Leadership - Truven · Micromedex · Merge
  7. [7]
    Clinical Decision Support Solutions - Merative
    Truven helps you make better, faster business decisions. We arm you with gold standard health data, easy-to-use analytics, and consulting services if you need ...Micromedex drug database · Explore DynaMedex · OrbitalRX with Micromedex
  8. [8]
    Medical Imaging Solutions and Software - Merative
    Discover Merge's award-winning medical imaging solutions for radiology, cardiology, and more. Streamline workflows, access AI tools, and face the future ...Merge Consulting Services · Explore Merge PACS · Merge Cardio 12.4Missing: key | Show results with:key
  9. [9]
    Healthcare analytics solutions | Truven - Merative
    Truven offers healthcare analytics solutions that deliver personalized care experiences by turning healthcare data into actionable insights.Flexible Analytics · Benefits Mentor · Health plans · Treatment Cost Calculator
  10. [10]
    Real-World Data (RWD) & Analytics - Merative
    Merative's RWD includes core claims data, linked specialty datasets like EHRs, mortality, and health data, and a linked Claims + EHR database.
  11. [11]
    50 years of Micromedex – a celebration of our history - Merative
    Mar 4, 2024 · Since the mid 1970s, Micromedex has been a pioneer in evidence-based clinical decision support. That's 50 years of supporting clients and ...Missing: establishment 1974
  12. [12]
    IBM and Partners to Transform Personal Health with Watson and ...
    Apr 13, 2015 · IBM launched the new Watson Health business unit to help patients, physicians, researchers and insurers use data to achieve better health and ...
  13. [13]
    IBM Closes Deal to Acquire Merge Healthcare - PR Newswire
    Oct 13, 2015 · PRNewswire/ -- IBM (NYSE: IBM) today announced that it has completed the acquisition of Merge Healthcare Incorporated, a leading provider of ...
  14. [14]
    IBM Completes Acquisition of Curam Software - PR Newswire
    Dec 20, 2011 · IBM (NYSE: IBM) today announced that it has completed its acquisition of Curam Software Ltd. The company expands IBM's ability to help cities and governments ...Missing: history | Show results with:history
  15. [15]
    IBM Watson Health Announces Plans to Acquire Truven Health ...
    Feb 18, 2016 · IBM Watson Health plans to acquire Truven for $2.6B, adding 8,500 clients, 300M patient lives, and making IBM a leading health data company.
  16. [16]
    IBM to acquire Truven Health Analytics for $2.6 billion | Reuters
    Feb 18, 2016 · The Truven data will be integrated with Watson's data, used to identify health cost savings, improve healthcare outcomes, fight fraud and make ...
  17. [17]
    Francisco Partners to Acquire IBM's Healthcare Data and Analytics ...
    Jan 21, 2022 · IBM and Francisco Partners announced that the companies have signed a definitive agreement under which Francisco Partners will acquire ...
  18. [18]
    Merative Officially Welcomes Its India Global Capability and ...
    Aug 24, 2023 · Merative Officially Welcomes Its India Global Capability and Innovation Centres Across Bangalore, Hyderabad and Chennai. Thursday, August 24, ...
  19. [19]
    Morgan Health Invests in Merative to Help Employers Turn Health ...
    Dec 3, 2024 · “Merative is excited to partner with Morgan Health and build on our momentum,” said Gerry McCarthy, CEO of Merative.
  20. [20]
    Micromedex drug database - Merative
    Micromedex is more than a drug database. The robust evidence-based solutions and resources help inform clinical decisions throughout the patient care continuum.
  21. [21]
    Micromedex - Hakeem Health
    2,500+ drug monographs. Core drug reference Micromedex has 2,500+ comprehensive drug monographs, organized in Quick Answer or In-Depth format, to allow users to ...Missing: size | Show results with:size
  22. [22]
    The cost of patient safety: 3 considerations for hospital leadership on ...
    Apr 11, 2024 · “After integrating Micromedex into our EHR, we are now able to review 96 percent of the prescriptions that we issue. By reviewing almost all ...
  23. [23]
    Real world evidence | Merative
    What is MarketScan? A premium portfolio of data, services, and applications designed to help you strengthen, accelerate, and simplify your real-world evidence ...
  24. [24]
    [PDF] 2024 Merative MarketScan data publication and trademark guidelines
    General Description​​ The Merative™ MarketScan® Research Databases contain individual-level, de-identified, healthcare claims information from employers, health ...
  25. [25]
    MarketScan benchmarking - Merative
    Trusted data to help you compare your population's cost, use, and prevalence of healthcare services and benchmark across your industry, region, and more.<|separator|>
  26. [26]
    Clinical Data Management | Zelta - Merative
    Customize your clinical data management with Zelta. Manage clinical case studies and research across all phases. Learn more today!Electronic Data Capture (EDC) · RTSM, CTMS & ETMF for... · eCOA/ePRO
  27. [27]
    Electronic Data Capture (EDC) - Merative
    Zelta's electronic data capture system is a flexible and secure eClinical solution for executing clinical trials, including decentralized trials solutions.
  28. [28]
    how on-demand analytics reduces latency for faster decision-making
    Oct 23, 2024 · Reduce analytic latency in healthcare to enable faster decision-making, improve population health, and enhance cost control with real-time ...
  29. [29]
    Flexible Analytics - Merative
    Turn healthcare data into actionable insights. Add time-tested methodologies to your existing environment to close gaps in care and reduce costs.
  30. [30]
    Enterprise PACS System - Merative
    Merge PACS enhances workflows, simplifies reading, consolidates data, allows remote access, and has a rule-based engine for workload balancing.
  31. [31]
    Radiology Workflow Solutions – Merge Workflow Orchestrator
    Merge Workflow Orchestrator unifies radiology worklists, consolidates patient imaging information, and provides a single worklist for clinicians.
  32. [32]
    Enterprise Imaging solutions - Merative
    Vendor-neutral storage. Merge VNA stores medical imaging data from any vendor, making it easy for healthcare organizations to integrate data from various ...Image-Enable Your Healthcare... · Merge Vna (vendor Neutral... · Merge Universal ViewerMissing: FHIR | Show results with:FHIR
  33. [33]
    Merge Vendor Neutral Archive - Merative
    Merge VNA is a scalable, vendor-neutral archive that manages, secures, stores, and shares medical imaging data, consolidating storage and streamlining access.Simplify Workflows And Boost... · Any Image Type · Scalability And Flexible...Missing: HL7 FHIR
  34. [34]
    Cardiology Solutions - Merative
    Cardiology solutions from Merative automate data records management for clinicians across cardiology service lines.Missing: neutral HL7 FHIR
  35. [35]
    Navigate Imaging AI with Merge and Aidoc - Merative
    Professional services and staff augmentation for imaging organizations. Partnerships ... Navigate Imaging AI with Merge and Aidoc. Merge-Aidoc Partnership ...Missing: post- 2022 image segmentation anomaly detection
  36. [36]
    Three ways AI can enhance radiology imaging workflows – right now
    Dec 18, 2024 · AI enhances radiology workflows through intelligent worklist distribution, generative AI for reporting, and automated exam follow-up detection.Missing: post- 2022 anomaly
  37. [37]
    Micromedex launches AI-powered search for clinical decision support
    Sep 23, 2025 · The AI-powered search is purpose-built for drug content, offering quick and precise access to expertly curated information tailored to the ...
  38. [38]
    Conversational AI in healthcare: Innovation in action - Merative
    This post will explore use cases of conversational AI in healthcare, with a spotlight on clinical decision support and important safety considerations.Missing: pilots | Show results with:pilots
  39. [39]
    AI in clinical decision support: A game changer for healthcare?
    Oct 28, 2025 · What is Micromedex? Healthcare providers can equip their clinicians with current, rapid, reliable insights at the point of care with clinical ...
  40. [40]
    Linking MarketScan claims data with Veradigm EHR data - Merative
    Sep 30, 2024 · This new healthcare database unlocks the whole picture of patient care at an unparalleled depth by linking claims data with electronic health records.
  41. [41]
    Unlock insights with NLP-enhanced EHR and claims data - YouTube
    Mar 4, 2025 · Discover how MarketScan and Veradigm's NLP-enhanced EHR and claims data can provide unparalleled insights into cardiovascular disease costs, ...
  42. [42]
    Linked Claims + EHR Database - Merative
    See how the Linked Claims + EHR Database by MarketScan and Veradigm are providing a deep view into patient journeys, healthcare utilization, and costs.
  43. [43]
    AI in Clinical Decision Support | Micromedex - Merative
    Explore how AI is revolutionizing clinical decision support, helping healthcare leaders streamline workflows, enhance outcomes, and make informed decisions.
  44. [44]
    Merge at RSNA 2023: Bringing Microsoft Azure availability and ...
    Dec 7, 2023 · At this year's RSNA, we showcased some exciting new developments, including new innovation to our cloud-enabled Merge Imaging Suite that will help clients.
  45. [45]
    Merge takeaways from RSNA to guide your 2025 - Merative
    Dec 23, 2024 · Merge and Microsoft: A partnership on the Azure marketplace. Did you know that Merge solutions are transactable on the Microsoft Azure ...
  46. [46]
    Kyvos Announces its Strategic OEM Partnership with Merative
    Aug 8, 2023 · The partnership intends to deliver a modernized analytics architecture to healthcare service providers that will transform healthcare analytics ...
  47. [47]
    Building the next generation of MarketScan: A year in review and ...
    Nov 16, 2023 · About a year and a half ago, we said goodbye to IBM Watson Health and set off on an exhilarating journey of standing up a new company, Merative™ ...
  48. [48]
    Merge by Merative Partners with Indica Labs to Bring Digital ...
    Nov 27, 2023 · This partnership will enable healthcare organizations to seamlessly integrate digital pathology into Merge imaging solutions.
  49. [49]
    Merge March 2024 newsletter: Welcome back to Merge Community
    Mar 13, 2024 · In partnership with Therapixel, Merative is proud to offer this mammography innovation to help imaging organizations like yours improve breast ...<|separator|>
  50. [50]
    Reflecting on 2024 progress and partnering for the future - Merative
    Dec 20, 2024 · In 2025, we plan to accelerate these innovations, partnering with governments and technology providers to explore AI's potential in creating ...
  51. [51]
    https://www.merative.com/blog/merge-newsletter-march-2024
  52. [52]
    Databases - DynaMed - LSU Health New Orleans
    Clinically-organized summaries for nearly 3,200 disease and condition topics; Over 800 drug topic summaries; Reviews & literature surveillance for over 500 ...
  53. [53]
    DynaMedex | Evidence-Based - EBSCO Information Services
    DynaMedex combines the clinical expertise and extensive, curated disease content of DynaMed with the AI search capabilities of Micromedex.
  54. [54]
    AI Detects Interval Cancer | Density Deadline - The Imaging Wire
    Aug 29, 2024 · AI flagged 24% of the interval cancers and correctly localized 77%. AI localized a higher proportion of node-positive than node-negative cancers ...
  55. [55]
    Cúram - Merative
    Cúram is a software that empowers health and human services organizations to transform service delivery and help individuals access programs. It streamlines ...Cúram education and training · Coordinated Health and Social... · Child Welfare
  56. [56]
    Integrated Eligibility and Enrollment - Merative
    Human services end-to-end integrated eligibility and enrollment processes that provide manage health and social program delivery.
  57. [57]
    Cúram Software: Transforming social services and empowering ...
    Aug 6, 2025 · Cúram by Merative is a purpose-built solution for government social programs, offering out-of-the-box support for complex eligibility rules, ...
  58. [58]
    Truven Health Insights - Merative
    Truven Health Insights provides the data integration, analytics exploration, and actionable insights you need to strive for a healthier population and bottom ...
  59. [59]
    Healthcare provider solutions - Merative
    Healthcare provider solutions that prioritize patient care by streamlining workflows and leveraging data-driven insights.
  60. [60]
    Workflow orchestration to streamline radiology | Merge by Merative
    Enhance radiology workflow with Merge Imaging Suite for Workflow Orchestration. Our AI-driven solution unifies systems, automates case assignment, ...
  61. [61]
    Spotlight on patient safety: the global challenge of medication ...
    Sep 9, 2024 · Providing real-time alerts for potential medication errors, such as drug interactions, allergies, and contraindications, directly within the ...
  62. [62]
    3 reasons to prioritize integration of your clinical decision support ...
    Jan 29, 2024 · The evidence-based clinical content of Micromedex is now available during prescription, dispensing and medication administration. As a ...
  63. [63]
    Zelta Reviews in 2025 - SourceForge
    Merative ... The platform also supports decentralized trials (DCTs), providing tools for remote patient recruitment, monitoring, and real-time data analysis.
  64. [64]
    eCOA Clinical Trials Solution - Merative
    Zelta is a cloud-based unified clinical data management and acquisition platform with adaptable modules that can be tailored to meet the unique needs of your ...<|separator|>
  65. [65]
    Take the hybrid road to bring clinical trials to patients | pharmaphorum
    Jan 23, 2024 · ... remote patient monitoring with wearable devices, and other digital ... Jennifer Duff is GM of Zelta Clinical Trials Solutions at Merative.
  66. [66]
    https://www.merative.com/clinical-development/ecoa-clinical-trials
  67. [67]
    Impact of State Telehealth Parity Laws for Private Payers on ...
    State telehealth payment parity laws were significantly associated with greater medication adherence, whereas coverage parity laws were not.
  68. [68]
    Behavioral telehealth: In it for the long haul - Merative
    Jan 20, 2023 · Telehealth appointments can provide more personalized health services, while lowering costs and improving access to care.Missing: AWS | Show results with:AWS
  69. [69]
    How Microsoft and Nuance empower radiologists with AI-powered ...
    Dec 1, 2023 · Microsoft and Nuance are committed to creating outcomes-focused AI solutions that streamline radiology workflows.Missing: Merative | Show results with:Merative
  70. [70]
    Top U.S. AI in Healthcare Companies and Recent Developments
    Oct 29, 2025 · DeepMind AI for Imaging: Applied in detecting eye disease and breast cancer. Strengths. World-leading AI research capabilities through DeepMind.
  71. [71]
    Faster Training and Inference: Habana Gaudi®-2 vs Nvidia A100 ...
    Mar 3, 2023 · Gaudi2 is about twice faster than Nvidia A100 80GB for both training and inference, and has 96GB memory per device compared to A100's 80GB.Missing: Merative analytics
  72. [72]
    Epic sees largest net gain in EHR market share in 2024: KLAS
    May 2, 2025 · The health IT company now commands 42.3% of the acute care EHR market, up from 39.1% a year prior. In 2024, 10 large health systems chose Epic ...
  73. [73]
    https://www.nature.com/articles/s41586-019-1799-6
  74. [74]
    Merative MarketScan Research Databases
    Merative MarketScan is one of the largest and longest running proprietary US claims databases used for healthcare research.
  75. [75]
    Merative's $25M funding, Risant closes on Cone Health, Aya buys ...
    December 6, 2024 | by Donna Cusano. Merative data analytics raises $25 million from Morgan Health. The latter, a JPMorgan Chase business unit focused on ...
  76. [76]
    Consolidation Surge Hits Healthtech - WSJ
    Sep 25, 2025 · Mergers and acquisitions of healthcare-technology startups jump as profitable companies pick off smaller players.
  77. [77]
    Healthcare Analytics Market to Hit USD 133.19 Billion by 2029 with ...
    Oct 9, 2024 · Merative, formerly IBM Watson Health, is a healthcare data and analytics company acquired by Francisco Partners for more than USD 1 billion in ...
  78. [78]
    Morgan Health Invests in Merative to Help Employers Turn Health ...
    Jan 2, 2025 · Merative's solutions are differentiated in their ability to offer a more comprehensive integrated view of healthcare quality and cost. In ...<|control11|><|separator|>
  79. [79]
    [PDF] Merative US LP 100 Phoenix Drive Ann Arbor, Michigan 48108 USA
    applicable data privacy laws including HIPAA and the California Consumer Protection Act (“CCPA”). 5. Content and Related Security a. “Content” consists of all ...
  80. [80]
    GDPR Information (News) - Merative
    Dec 9, 2021 · Merative Social Program Management has the following documentation to assist customers in relation to addressing the General Data Protection Regulation.Missing: HIPAA | Show results with:HIPAA
  81. [81]
    Merative Privacy Statement
    This privacy statement (“Privacy Statement”) describes how Merative LP (“Merative” “us”, “we”) generally collects, uses, and shares your information.Missing: GDPR | Show results with:GDPR
  82. [82]
    The rise of artificial intelligence in pharmacy practice - Merative
    May 16, 2025 · AI is already transforming pharmacy practice by integrating into daily workflows to enhance efficiency and improve patient outcomes.
  83. [83]
    After IBM intensely lobbied for AI deregulation in 21st Century Cures ...
    Oct 5, 2017 · IBM has lobbied lawmakers to insulate Watson from FDA oversight. The agency says it will release new guidance next year. For several years, IBM ...Missing: Merative controversies violations